JPRN-jRCT2080220350未知3 期
Double-blind study of VAA489 in patients with essential hypertension (factorial study)
ovartis Pharma K.K.0 个研究点目标入组 1,404 人开始时间: 2007年2月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 1,404
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Inclusion criteria
- •- Essential hypertension
- •- Outpatients
- •- Male or female aged 20 to 80 years old
- •Exclusion criteria
- •- Secondary hypertension or suspected of having secondary hypertension
- •- A history of malignant hypertension
- •- Severe hypertension
- •- Significant heart, renal, hepatic diseases or significant cerebrovascular disorder
- •Other protocol-defined inclusion/exclusion criteria may apply
排除标准
- 未提供
研究者
相似试验
未知
3 期
Double-blind study of VAH631 in patients with essential hypertension (factorial study)HypertensionJPRN-jRCT2080220234ovartis Pharma K.K.558
招募中
3 期
Study to compare the Efficacy and Safety of BCD-264 in the treatment of Relapsed and Refractory Multiple MyelomaCTRI/2024/03/063867JSC BIOCAD, Russia
进行中（未招募）
3 期
A clinical study to see to efficacy and safety of bcd-201 (Pembrolizumab) and Keytruda® for treatment in patients with unresolvable or evolved skin cancer.CTRI/2022/12/048496JSC BIOCAD
招募中
3 期
Phase III confirmatory study of in patients with venous malformation, lymphatic malformation and Klippel-Trenaunay SyndromeVenous malformation, Lymphatic malformation, Klippel-Trenaunay SyndromeJPRN-jRCT2041230064Hideki Kawabata32
进行中（未招募）
不适用
Phase II study of VELCADE in patients with extranodal marginal zone B-cell lymphoma of MALT-type pretreated with one prior systemic therapy regimetreatment of extranodal marginal zone B-cell non Hodgkin lymphoma of MALT type with bortezomibMedDRA version: 14.1Level: PTClassification code 10015823Term: Extranodal marginal zone B-cell lymphoma (MALT type) recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2004-004594-29-ITINTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)35